Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

CUSIP: 23285D109

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock - $0.001 par value
Shares outstanding
127,940,509
Total 13F shares
80,524,601
Share change
+1,674,104
Total reported value
$540,295,292
Put/Call ratio
236%
Price per share
$6.71
Number of holders
119
Value change
+$11,110,651
Number of buys
64
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 23285D109?
CUSIP 23285D109 identifies CTKB - Cytek Biosciences, Inc. - Common Stock - $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) as of Q1 2024

As of 31 Mar 2024, Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) was held by 119 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,524,601 shares. The largest 10 holders included BlackRock Inc., BROWN CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., STATE STREET CORP, NEW YORK STATE COMMON RETIREMENT FUND, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 120 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.